Office Headquarters: (610) 544-3500

perirx log in button

PeriRx Logo

 

Get News and Updates

 

eco

CLIA: 39D2085645

PeriRx on Facebook PeriRx on YouTube PeriRx on Google+ Stephen M. Swanick LinkedIn

ny

New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval. 

Order Brochures

PeriRx offers our test providers use of extensive patient and practice informational brochures to educate your team members and patients about the importance of Salivary Diagnostics Testing, and also inform them that you are a SaliMark™ OSCC test provider. Please call and speak with our marketing representatives in Broomall, Pennsylvania Corporate Headquarters to request your complimentary brochures. In addition you can also place your order through our “Contact Us” section of our Perirx.com website.

These brochures can also be conveniently downloaded and displayed within your own office.

 

brochure3SaliMark™ OSCC Tech Brief for Oral Surgeons

SaliMark developed by PeriRx is a game-changing salivary DNA test for oral cancer available to oral surgeons. SaliMark can detect oral cancer in stages 1 and 2, where it is most successfully treated.

 

 

 

 

 

brochure1SaliMark™ OSCC Tech Brief for Dentists

SaliMark developed by PeriRx is a game-changing salivary DNA test for oral cancer available to dentists. SaliMark can detect oral cancer in stages 1 and 2, where it is most successfully treated.

 

 

 

 

brochure2SaliMark™ OSCC Tech Brief for ENT’s

SaliMark developed by PeriRx is a game-changing salivary DNA test for oral cancer available to ENTs. SaliMark can detect oral cancer in stages 1 and 2, where it is most successfully treated.

 

 

 

 

 

 

SaliMark™ OSCC Dentist Brochure

Dentist Brochure

In addition to providing an overview of the current disease state of oral cancer, this brochure calls attention to its causes – including widespread lack of oral cancer screening, and alarming survival rates. Also examined briefly are the pros and cons of visual fluorescence and the fact that the majority of biopsies are negative. In this context, the SaliMark™ OSCC test is explained as being a valuable adjunct to any type of visual screening with the potential to reduce the number of negative biopsies, detect oral cancer sooner, and elevate survival rates. Click here for a Reference List.

Patient Algorithm Chart

This graphic, in a simple decision tree format, explains the procedure for using the SaliMark™ OSCC test after visually detecting a suspicious lesion or abnormality, as well as outlining the recommended referral protocol based on whether the lab report’s risk assessment of the patient are Low, Medium or High.

SaliMark™ OSCC Hygienist Brochure

Hygienist Brochure

An education tool for the dental hygienists that explains the risks and symptoms of oral cancer and the hygienist’s important role in screening and early detection – including administering the SaliMark™ OSCC test within a routine hygiene exam. Click here for a Reference List.

SaliMark™ OSCC Patient Brochure

Patient Brochure

This patient education tool explains oral cancer risks and statistics as well as how the accuracy of a thorough oral cancer screening exam is improved with the use of the SaliMark™ OSCC test for oral squamous cell carcinoma. Designed to be displayed in the dental practice waiting room. Click here for a Reference List.

SaliMark™ OSCC Clinical Trials Flyer

SaliMark™ OSCC Clinical Trials Flyer

More than a decade of National Institute of Dental and Craniofacial Research and National Institute of Health- supported research make SaliMark™ OSCC the world’s most clinically-advanced and scientifically-validated molecular DNA test for oral squamous cell carcinoma. This flyer explains the science and what it means to the dental clinician and patient alike.

SaliMark™ OSCC Introduction Flyer

SaliMark™ OSCC Introductory Flyer

This flyer provides a useful overview of the oral cancer disease state, the efficacy of the SaliMark™ OSCC Test, and how it fits into a comprehensive oral cancer screening protocol. Also included is how to interpret test results and the suggested referral protocol.